PeRfusiOn Post tHrombEcTomy (PROPHET) A Prospective Observational Cohort Study

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

Endovascular mechanical thrombectomy is the standard of care for treating patients with a large-vessel occlusion acute ischemic stroke. However, in more than half of these patients, remaining distal vessel occlusions limit the benefit of this therapy. Currently the detection of residual vessel occlusions and the decision for further treatment by the operator is based on the 2D digital subtraction angiography (DSA) images. However, this technique has several limitations. Recently, a new imaging technique, with the possibility to acquire 3D time-resolved perfusion images directly in the operating room was introduced (the flat-panel detector computed tomography perfusion imaging, FDCTP). It can overcome the spatial limitations of 2D DSA, but the details on clinical validation and utility of FDCTP are currently lacking.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Informed consent as documented by a signature

• The patients received mechanical thrombectomy or there was the intention to perform endovascular treatment, but only diagnostic angiography was performed.

• Patients received FDCTP as clinically indicated by the treating physician.

Locations
Other Locations
Switzerland
University Hospital Basel
NOT_YET_RECRUITING
Basel
University Hospital Bern
RECRUITING
Bern
Contact Information
Primary
Johannes Kaesmacher, Prof.
nctu@insel.ch
+41 31 66 4 05 38
Backup
Seraina Beyeler, PhD
seraina.beyeler@insel.ch
+41 31 632 39 70
Time Frame
Start Date: 2024-11-01
Estimated Completion Date: 2028-02-28
Participants
Target number of participants: 279
Treatments
Flat-panel detector computed tomography perfusion imaging, FDCTP
Potential clinical use of FDCTP acquired during or shortly after the endovascular stroke treatment
Related Therapeutic Areas
Sponsors
Leads: Insel Gruppe AG, University Hospital Bern

This content was sourced from clinicaltrials.gov